These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36460903)

  • 1. Emergency vaccination of cattle against lumpy skin disease: Evaluation of safety, efficacy, and potency of MEVAC
    Bazid AH; Wasfy M; Fawzy M; Nayel M; Abdelmegeid M; Thabet RY; Yong HS; El-Sayed MM; Magouz A; Badr Y
    Vet Res Commun; 2023 Jun; 47(2):767-777. PubMed ID: 36460903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the safety, immunogenicity and efficacy of three capripoxvirus vaccine strains against lumpy skin disease virus.
    Gari G; Abie G; Gizaw D; Wubete A; Kidane M; Asgedom H; Bayissa B; Ayelet G; Oura CA; Roger F; Tuppurainen ES
    Vaccine; 2015 Jun; 33(28):3256-61. PubMed ID: 26056063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy of Neethling lumpy skin disease virus and x10RM65 sheep-pox live attenuated vaccines for the prevention of lumpy skin disease - The results of a randomized controlled field study.
    Ben-Gera J; Klement E; Khinich E; Stram Y; Shpigel NY
    Vaccine; 2015 Sep; 33(38):4837-42. PubMed ID: 26238726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Goatpox virus (G20-LKV) vaccine strain elicits a protective response in cattle against lumpy skin disease at challenge with lumpy skin disease virulent field strain in a comparative study.
    Zhugunissov K; Bulatov Y; Orynbayev M; Kutumbetov L; Abduraimov Y; Shayakhmetov Y; Taranov D; Amanova Z; Mambetaliyev M; Absatova Z; Azanbekova M; Khairullin B; Zakarya K; Tuppurainen E
    Vet Microbiol; 2020 Jun; 245():108695. PubMed ID: 32456811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field study on the use of vaccination to control the occurrence of lumpy skin disease in Ethiopian cattle.
    Molla W; Frankena K; Gari G; de Jong MCM
    Prev Vet Med; 2017 Nov; 147():34-41. PubMed ID: 29254724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation on the incidence of adverse reactions, viraemia and haematological changes following field immunization of cattle using a live attenuated vaccine against lumpy skin disease.
    Katsoulos PD; Chaintoutis SC; Dovas CI; Polizopoulou ZS; Brellou GD; Agianniotaki EI; Tasioudi KE; Chondrokouki E; Papadopoulos O; Karatzias H; Boscos C
    Transbound Emerg Dis; 2018 Feb; 65(1):174-185. PubMed ID: 28391652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response against lumpy skin disease after simultaneous vaccination of cattle with sheep pox and goat pox and foot and mouth disease vaccines.
    Sareyyüpoğlu B; Uzar S; Saraç F; Enül H; Adıay C; Çokçalışkan C; Arslan A; Öztap G; Gülyaz V
    Vet Microbiol; 2023 Jun; 281():109726. PubMed ID: 37054661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines for lumpy skin disease, sheep pox and goat pox.
    Kitching RP
    Dev Biol (Basel); 2003; 114():161-7. PubMed ID: 14677686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of sheep pox virus vaccine for cattle against lumpy skin disease virus.
    Tuppurainen ES; Pearson CR; Bachanek-Bankowska K; Knowles NJ; Amareen S; Frost L; Henstock MR; Lamien CE; Diallo A; Mertens PP
    Antiviral Res; 2014 Sep; 109():1-6. PubMed ID: 24973760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an inactivated combined vaccine for protection of cattle against lumpy skin disease and bluetongue viruses.
    Es-Sadeqy Y; Bamouh Z; Ennahli A; Safini N; El Mejdoub S; Omari Tadlaoui K; Gavrilov B; El Harrak M
    Vet Microbiol; 2021 May; 256():109046. PubMed ID: 33780805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lumpy skin disease virus deficient of an IL-10 gene homologue provides protective immunity against virulent capripoxvirus challenge in sheep and goats.
    Boshra H; Truong T; Nfon C; Bowden TR; Gerdts V; Tikoo S; Babiuk LA; Kara P; Mather A; Wallace DB; Babiuk S
    Antiviral Res; 2015 Nov; 123():39-49. PubMed ID: 26341190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the safety, immunogenicity and efficacy of a new live-attenuated lumpy skin disease vaccine in India.
    Kumar N; Barua S; Kumar R; Khandelwal N; Kumar A; Verma A; Singh L; Godara B; Chander Y; Kumar G; Riyesh T; Sharma DK; Pathak A; Kumar S; Dedar RK; Mehta V; Gaur M; Bhardwaj B; Vyas V; Chaudhary S; Yadav V; Bhati A; Kaul R; Bashir A; Andrabi A; Yousuf RW; Koul A; Kachhawaha S; Gurav A; Gautam S; Tiwari HA; Munjal VK; Gupta MK; Kumar R; Gulati BR; Misri J; Kumar A; Mohanty AK; Nandi S; Singh KP; Pal Y; Dutt T; Tripathi BN
    Virulence; 2023 Dec; 14(1):2190647. PubMed ID: 36919498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental evaluation of the cross-protection between Sheeppox and bovine Lumpy skin vaccines.
    Hamdi J; Bamouh Z; Jazouli M; Boumart Z; Tadlaoui KO; Fihri OF; El Harrak M
    Sci Rep; 2020 Jun; 10(1):8888. PubMed ID: 32483247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological and clinical evaluation of the Yugoslavian RM65 sheep pox strain vaccine use in cattle against lumpy skin disease.
    Abutarbush SM; Tuppurainen ESM
    Transbound Emerg Dis; 2018 Dec; 65(6):1657-1663. PubMed ID: 29873893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Evaluation of an Inactivated Lumpy Skin Disease Vaccine for Cattle.
    Hamdi J; Boumart Z; Daouam S; El Arkam A; Bamouh Z; Jazouli M; Tadlaoui KO; Fihri OF; Gavrilov B; El Harrak M
    Vet Microbiol; 2020 Jun; 245():108689. PubMed ID: 32456824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of the optimal immunizing dose of heterologous goat pox virus vaccine (Poxviridae: Chordopoxvirinae: Capripoxvirus) against lumpy skin disease].
    Abitaev RT; Kondibaeva ZB; Amanova ZT; Sametova ZZ; Ussembay AK; Bulatov YA
    Vopr Virusol; 2022 Sep; 67(4):304-309. PubMed ID: 36097711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Reactions to Field Vaccination Against Lumpy Skin Disease in Jordan.
    Abutarbush SM; Hananeh WM; Ramadan W; Al Sheyab OM; Alnajjar AR; Al Zoubi IG; Knowles NJ; Bachanek-Bankowska K; Tuppurainen ES
    Transbound Emerg Dis; 2016 Apr; 63(2):e213-9. PubMed ID: 25098267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of putative immunomodulatory gene knockouts of lumpy skin disease virus in cattle towards an improved vaccine.
    Kara PD; Mather AS; Pretorius A; Chetty T; Babiuk S; Wallace DB
    Vaccine; 2018 Jul; 36(31):4708-4715. PubMed ID: 29941325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epizootic features and control measures for lumpy skin disease in south-east Serbia in 2016.
    Manić M; Stojiljković M; Petrović M; Nišavić J; Bacić D; Petrović T; Vidanović D; Obrenović S
    Transbound Emerg Dis; 2019 Sep; 66(5):2087-2099. PubMed ID: 31144436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effect of vaccination in xenogeneic animals.
    Shoulah SA; Elshafae SM; Gaballa MMS; Moussa MA; Selim A; Attia K; AlKahtani MDF; Albohairy FM
    Microb Pathog; 2022 May; 166():105541. PubMed ID: 35469999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.